Correlation Between Corvus Pharmaceuticals and Cidara Therapeutics
Can any of the company-specific risk be diversified away by investing in both Corvus Pharmaceuticals and Cidara Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Corvus Pharmaceuticals and Cidara Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Corvus Pharmaceuticals and Cidara Therapeutics, you can compare the effects of market volatilities on Corvus Pharmaceuticals and Cidara Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Corvus Pharmaceuticals with a short position of Cidara Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Corvus Pharmaceuticals and Cidara Therapeutics.
Diversification Opportunities for Corvus Pharmaceuticals and Cidara Therapeutics
0.59 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Corvus and Cidara is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Corvus Pharmaceuticals and Cidara Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cidara Therapeutics and Corvus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Corvus Pharmaceuticals are associated (or correlated) with Cidara Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cidara Therapeutics has no effect on the direction of Corvus Pharmaceuticals i.e., Corvus Pharmaceuticals and Cidara Therapeutics go up and down completely randomly.
Pair Corralation between Corvus Pharmaceuticals and Cidara Therapeutics
Given the investment horizon of 90 days Corvus Pharmaceuticals is expected to generate 5.67 times less return on investment than Cidara Therapeutics. But when comparing it to its historical volatility, Corvus Pharmaceuticals is 1.31 times less risky than Cidara Therapeutics. It trades about 0.09 of its potential returns per unit of risk. Cidara Therapeutics is currently generating about 0.41 of returns per unit of risk over similar time horizon. If you would invest 1,283 in Cidara Therapeutics on August 31, 2024 and sell it today you would earn a total of 737.00 from holding Cidara Therapeutics or generate 57.44% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Corvus Pharmaceuticals vs. Cidara Therapeutics
Performance |
| Timeline |
| Corvus Pharmaceuticals |
| Cidara Therapeutics |
Corvus Pharmaceuticals and Cidara Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Corvus Pharmaceuticals and Cidara Therapeutics
The main advantage of trading using opposite Corvus Pharmaceuticals and Cidara Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Corvus Pharmaceuticals position performs unexpectedly, Cidara Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cidara Therapeutics will offset losses from the drop in Cidara Therapeutics' long position.| Corvus Pharmaceuticals vs. Mereo BioPharma Group | Corvus Pharmaceuticals vs. Terns Pharmaceuticals | Corvus Pharmaceuticals vs. PDS Biotechnology Corp | Corvus Pharmaceuticals vs. Inozyme Pharma |
| Cidara Therapeutics vs. Cue Biopharma | Cidara Therapeutics vs. Eliem Therapeutics | Cidara Therapeutics vs. Inhibrx | Cidara Therapeutics vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |